<?xml version="1.0" encoding="UTF-8"?>
<ref id="bibr18-1759720X20947296">
 <label>18</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sanchez</surname>
    <given-names>GAM</given-names>
   </name>
   <name>
    <surname>Reinhardt</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Ramsey</surname>
    <given-names>S</given-names>
   </name>
  </person-group>, 
  <etal>et al</etal>
  <article-title>JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies</article-title>. 
  <source>J Clin Invest</source>
  <year>2018</year>; 
  <volume>128</volume>: 
  <fpage>3041</fpage>â€“
  <lpage>3052</lpage>.
  <pub-id pub-id-type="pmid">29649002</pub-id>
 </mixed-citation>
</ref>
